Daniel Dodge, DO
Pulmonary Disease · West Des Moines, IANPI 1124466032
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $6,388 with a category attached, or 93.9%. Intuitive Surgical accounts for 96.1% of it on its own, with 9 other manufacturers making up the rest.
Across 15 payments — averaging $425.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Veran Medical Technologies, Inc.$67
- KARL Storz Endoscopy-america$47
- Actelion Pharmaceuticals US, Inc.$39
- Astellas Pharma US Inc$20
- Itamar Medical Inc$20
- plus $58 from 4 others
What the payments were for
- Food & beverage$3886%
- Education$6,00094%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $6,137 |
| Veran Medical Technologies, Inc. | 1 | $67 |
| KARL Storz Endoscopy-america | 1 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $20 |
| Itamar Medical Inc | 1 | $20 |
| Fisher & Paykel Healthcare Inc | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Da Vinci Surgical System$3,000
How this compares
$6,388 in reported general payments places this provider in the 70th percentile of 110 pulmonary disease providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 529 | $391,592 |
| Breo ElliptaFluticasone/Vilanterol | 324 | $136,815 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 183 | $99,592 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 135 | $77,459 |
| Advair HfaFluticasone Propion/Salmeterol | 107 | $48,413 |
| Spiriva RespimatTiotropium Bromide | 81 | $44,159 |
| DuleraMometasone/Formoterol | 83 | $30,071 |
| Incruse ElliptaUmeclidinium Bromide | 63 | $29,094 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 234 | $28,875 |
| Arnuity ElliptaFluticasone Furoate | 112 | $27,726 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $25,960 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 50 | $20,614 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 27 | $18,446 |
| Spiriva HandihalerTiotropium Bromide | 25 | $17,753 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $9,130 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in West Des Moines
- Dustin McCannWest Des Moines$67K
- Matthew TrumpWest Des Moines$41K
- James MallenWest Des Moines$16K
- Samantha Danielson-JonesWest Des Moines$11K
- Ryan BrimeyerWest Des Moines$9K
- Amerlon EnriquezWest Des Moines$7K
- Ryan MertensWest Des Moines$6K
- John ScottWest Des Moines$3K
- Katrina GuestWest Des Moines$1K
- Gregory HicklinWest Des Moines$422
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.